First Patient in the US Dosed in a Global Multicentre Phase 3 Clinical Study of Bevacizumab for treatment of Ophthalmic Diseases
Feb 10, 2023 21:06 HKT |  |
|
Novotech Global Report: Robust Phase 1 Trial Growth Across Asia Pacific
Feb 10, 2023 19:00 HKT |  |
|
亚太地区细胞与基因研究：Novotech 的增长速度比世界其它地区快 50%
Feb 04, 2023 07:00 HKT | |
|
亞太地區細胞與基因研究：Novotech 的增長速度比世界其它地區快 50%
Feb 04, 2023 07:00 HKT | |
|
아시아 태평양 지역 세포유전자 연구: 노보텍이 세계의 나머지 모든 기관들보다 50% 더 빠르게 성장
Feb 04, 2023 07:00 HKT | |
|
Asia Pacific Cell & Gene Research Growing 50% Faster than ROW
Feb 03, 2023 13:00 HKT | |
|
Novotech Acquires US-based Drug Development Consulting Firm, CBR International
Jan 12, 2023 15:00 HKT | |
|
Novotech Acquires European CRO, Strengthens Global Operations
Jan 12, 2023 15:00 HKT | |
|
Novotech 收购美国药物开发咨询公司 CBR International
Jan 12, 2023 15:00 HKT | |
|
Novotech 收購美國藥物開發諮詢公司 CBR International
Jan 12, 2023 15:00 HKT | |
|
Novotech 收购欧洲 CRO——加强全球运营
Jan 12, 2023 15:00 HKT | |
|
Novotech 收購歐洲 CRO——加強全球運營
Jan 12, 2023 15:00 HKT | |
|
노보텍, 미국 기반의 의약품 개발 컨설팅 회사인 CBR 인터내셔널 인수
Jan 12, 2023 15:00 HKT | |
|
노보텍, 유럽 CRO 인수 - 글로벌 운영 강화
Jan 12, 2023 15:00 HKT | |
|
Avance Clinical 庆祝GlobalReady成功 超过40家生物技术客户进入计划
Jan 12, 2023 07:00 HKT |  |
|
Avance Clinical 慶祝GlobalReady成功 超過40家生物技術客戶進入計劃
Jan 12, 2023 07:00 HKT | |
|
아방스 클리니컬, GlobalReady 성공 축하 40개 이상의 생명공학 고객이 프로그램에 참여
Jan 12, 2023 07:00 HKT | |
|
HighTide Therapeutics Announces First Patient Dosed in Phase 2b Clinical Study Evaluating HTD1801 in NASH (the CENTRICITY study)
Jan 11, 2023 21:00 HKT |  |
|
Avance Clinical Celebrates GlobalReady Success as 40 Biotechs Join Program
Jan 11, 2023 15:00 HKT | |
|
君聖泰HTD1801治療非酒精性脂肪性肝炎（NASH）的臨床IIb 期研究（CENTRICITY研究）完成首例患者給藥
Jan 11, 2023 08:01 HKT | |
|